Merck KGaA (FRA:MRK)
Germany flag Germany · Delayed Price · Currency is EUR
111.50
-0.35 (-0.31%)
Last updated: Aug 14, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
200.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Life Science
-
Log In
Log In
Log In
Log In
Upgrade
Life Science Growth
-
Log In
Log In
Log In
Log In
Upgrade
Oncology
2.01B
Log In
Log In
Log In
Log In
Upgrade
Oncology Growth
3.98%
Log In
Log In
Log In
Log In
Upgrade
Neurology & Immunology
1.69B
Log In
Log In
Log In
Log In
Upgrade
Neurology & Immunology Growth
0.49%
Log In
Log In
Log In
Log In
Upgrade
Fertility
1.53B
Log In
Log In
Log In
Log In
Upgrade
Fertility Growth
-4.33%
Log In
Log In
Log In
Log In
Upgrade
Display Solutions
748.30M
Log In
Log In
Log In
Log In
Upgrade
Display Solutions Growth
-0.28%
Log In
Log In
Log In
Log In
Upgrade
Surface Solutions
406.50M
Log In
Log In
Log In
Log In
Upgrade
Surface Solutions Growth
-5.83%
Log In
Log In
Log In
Log In
Upgrade
Semiconductor Solutions
2.63B
Log In
Log In
Log In
Log In
Upgrade
Semiconductor Solutions Growth
0.60%
Log In
Log In
Log In
Log In
Upgrade
Cardiovascular, Metabolism and Endocrinology
2.95B
Log In
Log In
Log In
Log In
Upgrade
Cardiovascular, Metabolism and Endocrinology Growth
4.61%
Log In
Log In
Log In
Log In
Upgrade
Other Healthcare
280.50M
Log In
Log In
Log In
Log In
Upgrade
Other Healthcare Growth
19.95%
Log In
Log In
Log In
Log In
Upgrade
Process Solutions
3.52B
Log In
Log In
Log In
Log In
Upgrade
Process Solutions Growth
7.02%
Log In
Log In
Log In
Log In
Upgrade
Life Science Services
721.80M
Log In
Log In
Log In
Log In
Upgrade
Life Science Services Growth
-10.79%
Log In
Log In
Log In
Log In
Upgrade
Science & Lab Solutions
4.67B
Log In
Log In
Log In
Log In
Upgrade
Science & Lab Solutions Growth
-0.03%
Log In
Log In
Log In
Log In
Upgrade
Other
200.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBITDA by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Life Science EBITDA
2.59B
Log In
Log In
Log In
Log In
Upgrade
Life Science EBITDA Growth
4.80%
Log In
Log In
Log In
Log In
Upgrade
Healthcare EBITDA
2.99B
Log In
Log In
Log In
Log In
Upgrade
Healthcare EBITDA Growth
17.47%
Log In
Log In
Log In
Log In
Upgrade
Electronics EBITDA
969.60M
Log In
Log In
Log In
Log In
Upgrade
Electronics EBITDA Growth
-5.54%
Log In
Log In
Log In
Log In
Upgrade
Corporate/Others EBITDA
-481.80M
Log In
Log In
Log In
Log In
Upgrade
Corporate/Others EBITDA Growth
37.08%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Europe
6.17B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
5.01%
Log In
Log In
Log In
Log In
Upgrade
North America
5.71B
Log In
Log In
Log In
Log In
Upgrade
North America Growth
-2.84%
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific
7.02B
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific Growth
2.08%
Log In
Log In
Log In
Log In
Upgrade
Latin America
1.48B
Log In
Log In
Log In
Log In
Upgrade
Latin America Growth
3.00%
Log In
Log In
Log In
Log In
Upgrade
Middle East & Africa
781.20M
Log In
Log In
Log In
Log In
Upgrade
Middle East & Africa Growth
3.29%
Log In
Log In
Log In
Log In
Upgrade